Leaflet MESTINON 60mg sugar-coated tablets

Product code:
W57190001
Quantity:
20
Indicated for:
myasthenia gravis
Route of administration:
oral
Substance:
pyridostigmine bromide (cholinesterase inhibitor)
ATC
N07AA02 — Nervous system | Parasympathomimetics | Anticholinesterases
Pyridostigmine bromide is most commonly used for myasthenia gravis, a condition in which muscles tire quickly and become weak. It inhibits cholinesterase and increases acetylcholine at the junction between nerves and muscles. This can improve muscle strength, swallowing, speech, breathing and tolerance of daily activities.

It is taken by mouth, usually several times a day, because the effect lasts only a few hours. The dose is individualised according to symptoms, time of day, meals and activity needs. Do not change the dose on your own: too little may leave weakness uncontrolled, while too much may cause cramps, excessive secretions and worsening symptoms.

Common side effects include nausea, vomiting, diarrhoea, abdominal cramps, increased saliva, sweating, blurred vision, frequent urination, muscle cramps or twitching. Some people may develop slow heartbeat, low blood pressure, bronchial secretions, breathing difficulty or increased weakness. These symptoms may require dose adjustment.

Seek urgent medical help if breathing difficulty, severely impaired swallowing, fainting, very slow pulse, confusion or sudden worsening weakness occurs. Tell your doctor if you have asthma, lung disease, heart rhythm disorders, stomach ulcer, intestinal blockage or urinary obstruction. Pyridostigmine bromide controls symptoms, but does not cure the disease and should be part of neurological care.

General data about MESTINON 60mg

Substance:
pyridostigmine bromide
Date of latest medicines list:
01-06-2026
Product code:
W57190001
Concentration:
60mg
Pharmaceutical form:
sugar-coated tablets
Quantity:
20
Product type:
Generic medicine
Price:
18.61 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
LABIANA PHARMACEUTICALS S.L. - SPANIA
Holder:
MEDA AB - SUEDIA
Number:
11896/2019/01
Shelf life:
4 years; After first opening the bottle. - 3 months

Compensation lists for MESTINON 60mg Meda

G13 (C1) - Myasthenia gravis

Price
18.61 RON
Copayment
18.61 RON
Patient
0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price
18.61 RON
Copayment
18.61 RON
Patient
0.00 RON